Evidence map›Paper›PMID 42279277›Full record

ArticleCancers2026

Beyond Surgical Margins: Fully Mature Tertiary Lymphoid Structures (fmTLSs) Are Predictive Biomarkers for Local Recurrence in Primary Soft-Tissue Sarcomas.

Audrey Michot, Lucile Vanhersecke, Derek Dinart, Aurélien Bourdon, Rihab Azmani, Valérie Velasco, Iris Bonomo, Maïlys Toureille, Maud Toulmonde, Raul E Perret and 3 more

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Audrey MichotBordeaux Institute of Oncology, BRIC U1312 Team 9 Sarcotarget, INSERM, Université de Bordeaux, 33000 Bordeaux, France.
Lucile VanherseckeDepartment of Biopathology, Institut Bergonié, 33076 Bordeaux, France.ORCID 0000-0001-7733-7806
Derek DinartClinical and Epidemiological Research Unit, INSERM CIC1401, Institut Bergonié, 33076 Bordeaux, France.
Aurélien BourdonDepartment of Data and Digital Health, Institut Bergonié, 33076 Bordeaux, France.ORCID 0009-0007-9907-6214
Rihab AzmaniDepartment of Data and Digital Health, Institut Bergonié, 33076 Bordeaux, France.
Valérie VelascoDepartment of Biopathology, Institut Bergonié, 33076 Bordeaux, France.
Iris BonomoDepartment of Surgery, Institut Bergonié, 33000 Bordeaux, France.
Maïlys ToureilleDepartment of Biopathology, Institut Bergonié, 33076 Bordeaux, France.
Maud ToulmondeOncologic Unit, Institut Bergonié, 33076 Bordeaux, France.
Raul E PerretBordeaux Institute of Oncology, BRIC U1312 Team 9 Sarcotarget, INSERM, Université de Bordeaux, 33000 Bordeaux, France.ORCID 0000-0003-2698-0249
Carine BelleraClinical and Epidemiological Research Unit, INSERM CIC1401, Institut Bergonié, 33076 Bordeaux, France.
Jean-Michel CoindreDepartment of Biopathology, Institut Bergonié, 33076 Bordeaux, France.ORCID 0000-0001-8039-6786
François Le LoarerBordeaux Institute of Oncology, BRIC U1312 Team 9 Sarcotarget, INSERM, Université de Bordeaux, 33000 Bordeaux, France.ORCID 0000-0001-8582-9819

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerPrognostic factorsoft-tissue sarcoma (STS)tertiary lymphoid structures (TLS)tumor microenvironment

Identifiers

PMID42279277
PMCPMC13255587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.